TEX Form 144: 5,000 Shares from Restricted Stock Vesting to Be Sold on NYSE
Rhea-AI Filing Summary
Terex Corporation reports a proposed sale of 5,000 common shares through Fidelity Brokerage on the NYSE, with an aggregate market value of $252,500 against approximately 65.6 million shares outstanding. The shares to be sold were originally acquired as restricted stock vesting in five tranches between 03/02/2020 and 03/04/2024, totaling 5,000 shares. The filing states there were no securities sold in the past three months by the reporting person and includes the seller's representation regarding absence of undisclosed material adverse information. The planned sale date is 08/12/2025.
Positive
- Transparent disclosure: Filing specifies the proposed sale of 5,000 shares valued at $252,500.
- Origins disclosed: All shares were acquired via restricted stock vesting from 2020 to 2024, totaling 5,000 shares.
- No recent sales: The filing reports "Nothing to Report" for securities sold during the past three months.
Negative
- Insider sale planned: The reporting person intends to sell 5,000 shares, which will reduce their holdings (though the size is small relative to outstanding shares).
- Market exposure: The sale is scheduled on 08/12/2025, introducing short-term market exposure for those specific shares.
Insights
TL;DR: Small, routine insider sale; immaterial to overall capitalization given size relative to outstanding shares.
The filing notifies a proposed sale of 5,000 common shares valued at $252,500. Compared with approximately 65.6 million shares outstanding, the transaction is negligible in percentage terms (~0.0076%). All shares were acquired via restricted stock vesting between 2020 and 2024, indicating these are compensation-related holdings rather than recent open-market purchases. No sales were reported in the prior three months, and the broker is Fidelity Brokerage Services LLC. Overall investor impact is minimal.
TL;DR: Filing follows standard disclosure practice; provides transparency about insider compensation-derived shares and planned disposition.
The Form 144 lists the source of the securities as restricted stock vesting across five dates and states the seller's representation about lack of undisclosed material information. The presence of an explicit broker and the aggregate market value enhances traceability. The absence of prior three-month sales simplifies ownership change tracking. This is a routine disclosure consistent with governance and reporting norms.